Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies

DOI10.1002/SIM.9496MaRDI QIDQ6629386zbMATH OpenFDO

Authors Ying Yuan, Yixuan Zhao

Publication date 30 October 2024

Published in Statistics in Medicine (Search for Journal in Brave)

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies
• Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
• Bayesian optimal interval designs for phase I clinical trials
• gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points

This page was built for publication: Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629386)